Fed. Circ. Backs UK Pharma Firm's IP Win Against CBD Giant
The Federal Circuit upheld on Monday a win secured by British pharmaceutical firm GW Pharmaceuticals in a patent suit brought by cannabis giant Canopy Growth, which accused the former of pinching its extraction process so it could make its flagship CBD drug Epidiolex.